Endoplasmic reticulum stress and pancreatic β-cell death

Trends in Endocrinology and Metabolism

Volumn 22, Issue 7, 2011, Pages 266-274

  Fonseca, Sonya G ^a   Gromada, Jesper ^a   Urano, Fumihiko ^b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; CARBOXYPEPTIDASE H; FATTY ACID; GAMMA INTERFERON; GLUCAGON LIKE PEPTIDE 1; INITIATION FACTOR 2ALPHA; INSULIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; X BOX BINDING PROTEIN 1;

ARTICLE; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; CELL SURVIVAL; CELLULAR STRESS RESPONSE; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; GENETICS; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SYNTHESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN PHOSPHORYLATION; SINGLE NUCLEOTIDE POLYMORPHISM; UNFOLDED PROTEIN RESPONSE;

EID: 79959897450     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.02.008     Document Type: Review

References (100)

1. Melloul D., et al. Regulation of insulin gene transcription. Diabetologia 2002, 45:309-326.
2. Poitout V., et al. Regulation of the insulin gene by glucose and fatty acids. J. Nutr. 2006, 136:873-876.
3. Goodge K.A., Hutton J.C. Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic beta-cell. Semin. Cell Dev. Biol. 2000, 11:235-242.
4. Harding H.P., et al. Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival. Mol. Cell 2001, 7:1153-1163.
5. Scheuner D., et al. Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. Nat. Med. 2005, 11:757-764.
6. Eizirik D.L., et al. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 2008, 29:42-61.
7. Scheuner D., Kaufman R.J. The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. Endocr. Rev. 2008, 29:317-333.
8. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. 2007, 8:519-529.
9. Oslowski C.M., Urano F. The binary switch between life and death of endoplasmic reticulum-stressed beta cells. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17:107-112.
10. Vellanki R.N., et al. OASIS/CREB3L1 induces expression of genes involved in extracellular matrix production but not classical endoplasmic reticulum stress response genes in pancreatic beta-cells. Endocrinology 2010, 151:4146-4157.
11. Kondo S., et al. OASIS, a CREB/ATF-family member, modulates UPR signalling in astrocytes. Nat. Cell Biol. 2005, 7:186-194.
12. Schuit F.C., et al. Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:3865-3869.
13. Cnop M., et al. Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis. J. Biol. Chem. 2007, 282:3989-3997.
14. Oslowski C.M., Urano F. The binary switch that controls the life and death decisions of ER stressed beta cells. Curr. Opin. Cell Biol. 2010, [Epub ahead of print].
15. Oslowski C.M., Urano F. A switch from life to death in endoplasmic reticulum stressed beta-cells. Diabetes Obes. Metab. 2010, 12(Suppl. 2):58-65.
16. Szegezdi E., et al. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006, 7:880-885.
17. Prentki M., Nolan C.J. Islet beta cell failure in type 2 diabetes. J. Clin. Invest. 2006, 116:1802-1812.
18. Elouil H., et al. Acute nutrient regulation of the unfolded protein response and integrated stress response in cultured rat pancreatic islets. Diabetologia 2007, 50:1442-1452.
19. Lipson K.L., et al. Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab. 2006, 4:245-254.
20. Lipson K.L., et al. The Role of IRE1alpha in the Degradation of Insulin mRNA in Pancreatic beta-Cells. PLoS ONE 2008, 3:e1648.
21. Hou Z.Q., et al. Involvement of chronic stresses in rat islet and INS-1 cell glucotoxicity induced by intermittent high glucose. Mol. Cell. Endocrinol. 2008, 291:71-78.
22. Jonas J.C., et al. Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes. Diabetes Obes. Metab. 2009, 11(Suppl. 4):65-81.
23. Laybutt D.R., et al. Influence of diabetes on the loss of beta cell differentiation after islet transplantation in rats. Diabetologia 2007, 50:2117-2125.
24. Laybutt D.R., et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007, 50:752-763.
25. Robertson R.P., et al. Glucose toxicity of the beta-cell. Diabetes Mellitus 2004, 129-139. Lippincott Williams & Wilkins. D. LeRoith (Ed.).
26. Robertson R.P., et al. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003, 52:581-587.
27. Malhotra J.D., Kaufman R.J. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?. Antioxid. Redox Signal. 2007, 9:2277-2293.
28. Liew C.W., et al. The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J. Clin. Invest. 2010, 120:2876-2888.
29. Qian B., et al. TRIB3 [corrected] is implicated in glucotoxicity- and endoplasmic reticulum-stress-induced [corrected] beta-cell apoptosis. J. Endocrinol. 2008, 199:407-416.
30. Karaskov E., et al. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 2006, 147:3398-3407.
31. Gwiazda K.S., et al. Effects of palmitate on ER and cytosolic Ca2+ homeostasis in beta-cells. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E690-701.
32. Preston A.M., et al. Reduced endoplasmic reticulum (ER)-to-Golgi protein trafficking contributes to ER stress in lipotoxic mouse beta cells by promoting protein overload. Diabetologia 2009, 52:2369-2373.
33. Kharroubi I., et al. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 2004, 145:5087-5096.
34. Cunha D.A., et al. Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J. Cell Sci. 2008, 121:2308-2318.
35. Cardozo A.K., et al. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes 2005, 54:452-461.
36. Eizirik D.L., et al. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 1996, 39:875-890.
37. Akerfeldt M.C., et al. Cytokine-induced beta-cell death is independent of endoplasmic reticulum stress signaling. Diabetes 2008, 57:3034-3044.
38. Oyadomari S., et al. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10845-10850.
39. Cardozo A.K., et al. A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J. Biol. Chem. 2001, 276:48879-48886.
40. Tu B.P., Weissman J.S. Oxidative protein folding in eukaryotes: mechanisms and consequences. J. Cell Biol. 2004, 164:341-346.
41. Brissova M., Powers A.C. Revascularization of transplanted islets: can it be improved?. Diabetes 2008, 57:2269-2271.
42. Carlsson P.O., et al. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001, 50:489-495.
43. Carlsson P.O., et al. Low revascularization of experimentally transplanted human pancreatic islets. J. Clin. Endocrinol. Metab. 2002, 87:5418-5423.
44. Mattsson G., et al. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 2002, 51:1362-1366.
45. Kennedy J., et al. Protective unfolded protein response in human pancreatic beta cells transplanted into mice. PLoS ONE 2010, 5:e11211.
46. Herbach N., et al. Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice. Diabetes 2007, 56:1268-1276.
47. Colombo C., et al. Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J. Clin. Invest. 2008, 118:2148-2156.
48. Wang J., et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J. Clin. Invest. 1999, 103:27-37.
49. Masharani U., Karam J.H. Pancreatic Hormones and Diabetes Mellitus. Basic and Clinical Endocrinology 2001, 623-698. McGraw-Hill. F.S. Greenspan, D.G. Gardner (Eds.).
50. Yoshioka M., et al. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997, 46:887-894.
51. Kayo T., Koizumi A. Mapping of murine diabetogenic gene mody on chromosome 7 at D7Mit258 and its involvement in pancreatic islet and beta cell development during the perinatal period. J. Clin. Invest. 1998, 101:2112-2118.
52. Steiner D.F., et al. A brief perspective on insulin production. Diabetes Obes. Metab. 2009, 11(Suppl. 4):189-196.
53. Hodish I., et al. Misfolded proinsulin affects bystander proinsulin in neonatal diabetes. J. Biol. Chem. 2010, 285:685-694.
54. Liu M., et al. Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport. PLoS ONE 2010, 5:e13333.
55. Huang C.J., et al. Induction of endoplasmic reticulum stress-induced beta-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1656-1662.
56. Huang C.J., et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 2007, 56:2016-2027.
57. Ritzel R.A., et al. Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets. Diabetes 2007, 56:65-71.
58. Sawaya M.R., et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007, 447:453-457.
59. Hull R.L., et al. Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress. Diabetologia 2009, 52:1102-1111.
60. Matveyenko A.V., et al. Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced beta-cell endoplasmic reticulum stress. Diabetes 2009, 58:906-916.
61. Zhang W., et al. PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis. Cell Metab. 2006, 4:491-497.
62. Scheuner D., et al. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol. Cell 2001, 7:1165-1176.
63. Hollien J., et al. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J. Cell Biol. 2009, 186:323-331.
64. Hollien J., Weissman J.S. Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science (New York, N.Y.) 2006, 313:104-107.
65. Pirot P., et al. Global profiling of genes modified by endoplasmic reticulum stress in pancreatic beta cells reveals the early degradation of insulin mRNAs. Diabetologia 2007, 50:1006-1014.
66. Han D., et al. IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell 2009, 138:562-575.
67. Zito E., et al. ERO1-beta, a pancreas-specific disulfide oxidase, promotes insulin biogenesis and glucose homeostasis. J. Cell Biol. 2010, 188:821-832.
68. Nishitoh H., et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 2002, 16:1345-1355.
69. Urano F., et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science (New York, N.Y.) 2000, 287:664-666.
70. Yoneda T., et al. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J. Biol. Chem. 2001, 276:13935-13940.
71. Allagnat F., et al. Sustained production of spliced X-box binding protein 1 (XBP1) induces pancreatic beta cell dysfunction and apoptosis. Diabetologia 2010, 53:1120-1130.
72. Ishigaki S., et al. AATF mediates an antiapoptotic effect of the unfolded protein response through transcriptional regulation of AKT1. Cell Death Differ. 2010, 17:774-786.
73. Gupta S., et al. PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway. Diabetes 2010, 59:1937-1947.
74. Harding H.P., et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 2003, 11:619-633.
75. Zinszner H., et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 1998, 12:982-995.
76. Marciniak S.J., et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 2004, 18:3066-3077.
77. Galehdar Z., et al. Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA. J. Neurosci. 2010, 30:16938-16948.
78. Ohoka N., et al. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 2005, 24:1243-1255.
79. Bromati C.R., et al. UPR induces transient burst of apoptosis in islets of early lactating rats through reduced AKT phosphorylation via ATF4/CHOP stimulation of TRB3 expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R92-100.
80. Li G., et al. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J. Cell Biol. 2009, 186:783-792.
81. Seo H.Y., et al. Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases insulin gene expression via up-regulation of orphan nuclear receptor small heterodimer partner. Endocrinology 2008, 149:3832-3841.
82. Song B., et al. Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J. Clin. Invest. 2008, 118:3378-3389.
83. Franks P.W., et al. Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia 2008, 51:458-463.
84. Schafer S.A., et al. A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion. Diabetologia 2009, 52:1075-1082.
85. Sparso T., et al. Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation. Diabetologia 2008, 51:1646-1652.
86. Marchetti P., et al. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 2007, 50:2486-2494.
87. Marselli L., et al. Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS ONE 2010, 5:e11499.
88. Lin J.H., et al. IRE1 signaling affects cell fate during the unfolded protein response. Science (New York, N.Y.) 2007, 318:944-949.
89. Rutkowski D.T., et al. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol. 2006, 4:e374.
90. Butler A.E., et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
91. Sakuraba H., et al. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 2002, 45:85-96.
92. Rahier J., et al. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes. Metab. 2008, 10(Suppl. 4):32-42.
93. Drucker D.J. The biology of incretin hormones. Cell Metab. 2006, 3:153-165.
94. Yusta B., et al. GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab. 2006, 4:391-406.
95. Voight B.F., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010, 42:579-589.
96. Dupuis J., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 2010, 42:105-116.
97. Sladek R., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
98. Zeggini E., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science (New York, N.Y.) 2007, 316:1336-1341.
99. Saxena R., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (New York, N.Y.) 2007, 316:1331-1336.
100. Scott L.J., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (New York, N.Y.) 2007, 316:1341-1345.